Federated Hermes’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.29M | Sell |
293,842
-146,042
| -33% | -$4.61M | 0.02% | 588 |
|
2025
Q1 | $14.6M | Sell |
439,884
-52,919
| -11% | -$1.76M | 0.03% | 471 |
|
2024
Q4 | $17M | Sell |
492,803
-49,276
| -9% | -$1.7M | 0.04% | 444 |
|
2024
Q3 | $21.7M | Buy |
542,079
+16,555
| +3% | +$662K | 0.05% | 405 |
|
2024
Q2 | $15.9M | Sell |
525,524
-17
| -0% | -$513 | 0.04% | 447 |
|
2024
Q1 | $17.6M | Buy |
525,541
+204
| +0% | +$6.85K | 0.04% | 441 |
|
2023
Q4 | $17M | Buy |
525,337
+501,809
| +2,133% | +$16.2M | 0.04% | 426 |
|
2023
Q3 | $771K | Buy |
23,528
+355
| +2% | +$11.6K | ﹤0.01% | 1208 |
|
2023
Q2 | $815K | Sell |
23,173
-15,363
| -40% | -$541K | ﹤0.01% | 1204 |
|
2023
Q1 | $1.26M | Buy |
38,536
+9,013
| +31% | +$294K | ﹤0.01% | 1097 |
|
2022
Q4 | $1.63M | Buy |
29,523
+2,242
| +8% | +$124K | ﹤0.01% | 977 |
|
2022
Q3 | $1.21M | Sell |
27,281
-12,120
| -31% | -$537K | ﹤0.01% | 1061 |
|
2022
Q2 | $1.92M | Buy |
39,401
+11,146
| +39% | +$543K | 0.01% | 941 |
|
2022
Q1 | $1.38M | Buy |
+28,255
| New | +$1.38M | ﹤0.01% | 1137 |
|